Gilad Hamdani1, Edward J Nehus, Coral D Hanevold, Judith Sebestyen Van Sickle, Robert Woroniecki, Scott E Wenderfer, David K Hooper, Douglas Blowey, Amy Wilson, Bradley A Warady, Mark M Mitsnefes. 1. 1 Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 2 Division of Pediatric Nephrology, Seattle Children's Hospital, Seattle, WA. 3 Division of Pediatric Nephrology, Children's Mercy Hospital, Kansas City, MO. 4 Division of Pediatric Nephrology, Stony Brook University Hospital, New York, NY. 5 Pediatric Renal Section, Texas Children's Hospital, Baylor College of Medicine, Houston, TX. 6 Division of Nephrology and Hypertension, J.W. Riley Hospital for Children, Indianapolis, IN.
Abstract
BACKGROUND: Hypertension is a common complication and is an important risk factor for graft loss and adverse cardiovascular outcomes in pediatric kidney transplantation. Ambulatory blood pressure monitoring (ABPM) is the preferred method to characterize blood pressure status. METHODS: We conducted a retrospective review of a large cohort of children and young adults with kidney transplant to estimate the prevalence of abnormal ambulatory blood pressure (ABP), assess factors associated with abnormal ABP, and examine whether ambulatory hypertension is associated with worse allograft function and left ventricular hypertrophy (LVH). RESULTS: Two hundred twenty-one patients had ABPM, and 142 patients had echocardiographic results available for analysis. One third of the patients had masked hypertension, 32% had LVH, and 38% had estimated glomerular filtration rate less than 60 mL/min per 1.73 m. African-American race/Hispanic ethnicity and requirement for more than 1 antihypertensive medication were independently associated with having masked hypertension. In a multivariate analysis, abnormal blood pressure (masked or sustained hypertension combined) was an independent predictor for LVH among patients not receiving antihypertensive treatment (P = 0.025). In a separate analysis, the use of antihypertensive medications was independently associated with worse allograft function (P = 0.002) although abnormal blood pressure was not a significant predictor. CONCLUSIONS: In young kidney transplant recipients, elevated ABP is frequently unrecognized and undertreated. The high prevalence of abnormal ABP, including masked hypertension, and its association with LVH supports the case for routine ABPM and cardiac structure evaluation as the standard of care in these patients.
BACKGROUND:Hypertension is a common complication and is an important risk factor for graft loss and adverse cardiovascular outcomes in pediatric kidney transplantation. Ambulatory blood pressure monitoring (ABPM) is the preferred method to characterize blood pressure status. METHODS: We conducted a retrospective review of a large cohort of children and young adults with kidney transplant to estimate the prevalence of abnormal ambulatory blood pressure (ABP), assess factors associated with abnormal ABP, and examine whether ambulatory hypertension is associated with worse allograft function and left ventricular hypertrophy (LVH). RESULTS: Two hundred twenty-one patients had ABPM, and 142 patients had echocardiographic results available for analysis. One third of the patients had masked hypertension, 32% had LVH, and 38% had estimated glomerular filtration rate less than 60 mL/min per 1.73 m. African-American race/Hispanic ethnicity and requirement for more than 1 antihypertensive medication were independently associated with having masked hypertension. In a multivariate analysis, abnormal blood pressure (masked or sustained hypertension combined) was an independent predictor for LVH among patients not receiving antihypertensive treatment (P = 0.025). In a separate analysis, the use of antihypertensive medications was independently associated with worse allograft function (P = 0.002) although abnormal blood pressure was not a significant predictor. CONCLUSIONS: In young kidney transplant recipients, elevated ABP is frequently unrecognized and undertreated. The high prevalence of abnormal ABP, including masked hypertension, and its association with LVH supports the case for routine ABPM and cardiac structure evaluation as the standard of care in these patients.
Authors: Tomás Seeman; Eva Simková; Jirí Kreisinger; Karel Vondrák; Jirí Dusek; Jirí Gilík; Janusz Feber; Pavel Dvorák; Jan Janda Journal: Pediatr Transplant Date: 2006-05
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Circulation Date: 2005-02-08 Impact factor: 29.690
Authors: Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer Journal: N Engl J Med Date: 2009-10-22 Impact factor: 91.245
Authors: Gina-Marie Barletta; Christopher Pierce; Mark Mitsnefes; Joshua Samuels; Bradley A Warady; Susan Furth; Joseph Flynn Journal: Hypertension Date: 2018-01-02 Impact factor: 10.190
Authors: Michael E Seifert; Devesh S Dahale; Margret Kamel; Pamela D Winterberg; Gina-Marie Barletta; Craig W Belsha; Abanti Chaudhuri; Joseph T Flynn; Rouba Garro; Roshan P George; Jens W Goebel; David B Kershaw; Debora Matossian; Jason Misurac; Corina Nailescu; Christina R Nguyen; Meghan Pearl; Ari Pollack; Cozumel S Pruette; Pamela Singer; Judith S VanSickle; Priya Verghese; Bradley A Warady; Andrew Warmin; Patricia L Weng; Larysa Wickman; Amy C Wilson; David K Hooper Journal: Pediatrics Date: 2020-06-09 Impact factor: 7.124
Authors: Gilad Hamdani; Edward J Nehus; Coral D Hanevold; Judith S VanSickle; David K Hooper; Doug Blowey; Bradley A Warady; Mark M Mitsnefes Journal: Am J Hypertens Date: 2017-10-01 Impact factor: 2.689
Authors: John G Rizk; Jose G Lazo; David Quan; Steven Gabardi; Youssef Rizk; Elani Streja; Csaba P Kovesdy; Kamyar Kalantar-Zadeh Journal: Rev Endocr Metab Disord Date: 2021-07-22 Impact factor: 6.514